Director, Enterprise Specialty Clinical Solutions
MedImpact Healthcare Systems, Inc.
Dr. Trieu is currently the Director of Enterprise Specialty Clinical Solutions for MedImpact and is responsible for clinical aspects of the MedImpact Specialty Programs. Dr. Trieu previously led surveillance and strategy for pipeline compounds for the Emerging Therapeutics Strategy Team at MedImpact. In this role she tracked pipeline agents in development, developed budget impact models for high-interest pipeline agents and new drugs, and for providing clinical strategy for pipeline agents and recently approved drugs.
Dr. Trieu currently holds an adjunct faculty position at the University of North Texas and previously volunteered as adjunct faculty at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Trieu received her Doctor of Pharmacy degree from the University of Missouri-Kansas City. She went on to complete the Rutgers Pharmaceutical Industry Fellowship with Novartis Pharmaceuticals with a focus on regulatory affairs and marketing. Prior to joining MedImpact she spent 10 years working for various large pharmaceutical companies in Medical Affairs.
Thursday, March 28
11:15 AM – 12:30 PM